New Targeted Therapies in Clinical Cancer Research – Impact Factor 10.199
Targeted therapies represent a significant advancement in cancer treatment methodology, departing from conventional approaches that affect both malignant and healthy cells without discrimination. These treatments are engineered to selectively target cancer cells by exploiting their distinct molecular profiles, resulting in reduced damage to normal tissue and fewer adverse effects. The advancement of targeted therapies has […]
New Targeted Therapies in Clinical Cancer Research – Impact Factor 10.199 Read More »










